Michael Rangel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michael Rangel has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Jerry Kong
Rutgers Cancer Institute of New Jersey New Brunswick NJ USA
1 shared publication- Jessie Yanxiang Guo
Rutgers Cancer Institute, New Brunswick, USA
1 shared publication Khoosheh Khayati
Rutgers Cancer Institute of New Jersey New Brunswick NJ USA
1 shared publicationVrushank Bhatt
Rutgers Cancer Institute of New Jersey New Brunswick NJ USA
1 shared publication
Latest Publications
- Open Access
- 28 July 2021
- Published by Wiley in The FEBS Journal
- Vol. 289 (22) , 7177-7198
Autophagy and tumorigenesis
Autophagy is a catabolic process that captures cellular waste and degrades them in the lysosome. The main functions of autophagy are quality control of cytosolic proteins and organelles, and intracellular recycling of nutrients in order to maintain cellular homeostasis. Autophagy is upregulated in many cancers to promote cell survival, proliferation, and metastasis. Both cell‐autonomous autophagy (also known as tumor autophagy) and non‐cell‐autonomous autophagy (also known as host autophagy) support tumorigenesis through different mechanisms, including inhibition of p53 activation, sustaining redox homeostasis, maintenance of essential amino acids levels in order to support energy production and biosynthesis, and inhibition of antitumor immune responses. Therefore, autophagy may serve as a tumor‐specific vulnerability and targeting autophagy could be a novel strategy in cancer treatment.
- 28 July 2021
- Published by Wiley in The FEBS Journal
- Vol. 289 (22) , 7177-7198
Open AccessAutophagy and tumorigenesis
Autophagy is a catabolic process that captures cellular waste and degrades them in the lysosome. The main functions of autophagy are quality control of cytosolic proteins and organelles, and intracellular recycling of nutrients in order to maintain cellular homeostasis. Autophagy is upregulated in many cancers to promote cell survival, proliferation, and metastasis. Both cell‐autonomous autophagy (also known as tumor autophagy) and non‐cell‐autonomous autophagy (also known as host autophagy) support tumorigenesis through different mechanisms, including inhibition of p53 activation, sustaining redox homeostasis, maintenance of essential amino acids levels in order to support energy production and biosynthesis, and inhibition of antitumor immune responses. Therefore, autophagy may serve as a tumor‐specific vulnerability and targeting autophagy could be a novel strategy in cancer treatment.